These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16644904)

  • 41. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
    Wichems CH; Hollingsworth CK; Bennett BA
    Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
    Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
    Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines.
    Hilber B; Scholze P; Dorostkar MM; Sandtner W; Holy M; Boehm S; Singer EA; Sitte HH
    Neuropharmacology; 2005 Nov; 49(6):811-9. PubMed ID: 16185723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology.
    Reeve HL; Nelson DP; Archer SL; Weir EK
    Am J Physiol; 1999 Feb; 276(2):L213-9. PubMed ID: 9950882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
    Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
    Gobbi M; Funicello M; Gerstbrein K; Holy M; Moya PR; Sotomayor R; Forray MI; Gysling K; Paluzzi S; Bonanno G; Reyes-Parada M; Sitte HH; Mennini T
    J Neurochem; 2008 Jun; 105(5):1770-80. PubMed ID: 18248615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat.
    Matos FF; Rollema H; Brown JL; Basbaum AI
    Pain; 1992 Mar; 48(3):439-447. PubMed ID: 1375724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice.
    Bazhenova EY; Sinyakova NA; Kulikova EA; Kazarinova IA; Bazovkina DV; Gainetdinov RR; Kulikov AV
    Neurosci Lett; 2017 Jul; 653():264-268. PubMed ID: 28579486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
    Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
    Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
    Furlong TM; Leavitt LS; Keefe KA; Son JH
    Neurotox Res; 2016 May; 29(4):569-82. PubMed ID: 26846719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
    Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
    Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    Bel N; Artigas F
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD; Katz JL; Ricaurte GA
    Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G; Yeh SY; De Souza EB
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
    He M; Sibille E; Benjamin D; Toth M; Shippenberg T
    Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    Li Q; Murakami I; Stall S; Levy AD; Brownfield MS; Nichols DE; Van de Kar LD
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1261-7. PubMed ID: 8968349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.